TRUADVICE’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History
Bought
Maintained
Sold
Other funds holding BTAL
FDCDDQ
TWM
EFG
FGA
TRUADVICE's BTAL Position: Q3 2023 in Review
TRUADVICE increased its AGF US Market Neutral Anti-Beta Fund (BTAL) stake by 189% in Q3 2023, buying an estimated $551K and bringing the position to 44,458 shares worth $934K. The position accounts for 0.37% of the portfolio, ranked #77.
TRUADVICE first reported a position in BTAL in Q3 2020 and has held it in 13 quarters since. The position peaked at $1.3M in Q2 2021. 76 funds tracked by Wall St. Rank hold BTAL as of Q3 2023.
- TRUADVICE held 44,458 shares of AGF US Market Neutral Anti-Beta Fund worth $934K as of Q3 2023.
- TRUADVICE bought 29,077 AGF US Market Neutral Anti-Beta Fund shares in Q3 2023, an estimated $551K.
- AGF US Market Neutral Anti-Beta Fund made up 0.37% of TRUADVICE's portfolio in Q3 2023, its #77 holding.
- TRUADVICE first reported a position in AGF US Market Neutral Anti-Beta Fund in Q3 2020 and has held it in 13 quarters since.
- TRUADVICE's AGF US Market Neutral Anti-Beta Fund position peaked at $1.3M in Q2 2021.
- 76 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q3 2023.
Based on TRUADVICE's 13F filing for Q3 2023, filed 13 Nov 2023.